Education Zone
touchIME is the education division of touchONCOLOGY, we pride ourselves on providing innovative independent learning activities for busy healthcare professionals.
Stay up to date with the latest developments in EGFR+ NSCLC with our touchPANEL DISCUSSION with internationally renowned expert faculty discussing the use of TKIs in first line and beyond
Watch webinars and interviews that cover the latest developments in CDK4/6 inhibitors for patients with HR+/HER2- advanced breast cancer, from global experts at SABCS, ASCO, ESMO and ESMO Breast Cancer Congress 2019.
Watch the footage from our Satellite Symposium at the International Consensus Conference for Advanced Breast Cancer 2019 (ABC5), with internationally renowned expert faculty discussing the optimization of CDK4/6 inhibitor treatment in patients with advanced breast cancer.
Stay up to date with the latest developments in NSCLC with MET exon 14 skipping alterations with our touchCONGRESS Panel Discussion and Expert Interviews from the European Society for Medical Oncology (ESMO) Annual Meeting in Barcelona 27 September–1 October 2019.
Stay up to date with the latest developments in the management and treatment of patients with EGFR+ NSCLC with our touchCONGRESS Webinar and Expert Interviews from the ESMO Congress 2019 in Barcelona, Spain, 27 September–1 October 2019 and the ESMO Asia Congress 2019 in Singapore, 22–24 November, 2019.
Watch leading clinicians with a broad range of oncology expertise discuss the current challenges in treating solid tumours, what they expect from the 2019 European Society of Medical Oncology (ESMO) Congress, 27 September–1 October 2019, and what the latest data could mean for global and regional clinical practice.
Watch the footage from our Satellite Symposium at the 2019 ESMO Breast Cancer Annual Congress, with an internationally renowned expert faculty discussing the optimization of treatment with CDK4/6 inhibitors in HR+/HER2- breast cancer.
Watch internationally renowned experts discuss the selection of first-line treatments for patients with EGFR+ NSCLC and treatment sequencing, as well as the importance of biomarker testing and the emergence of treatment resistance.
Watch the footage from our Satellite Symposium at the 2019 St. Gallen International Breast Cancer Conference, with an internationally renowned expert faculty discussing the changing landscape for adjuvant treatment of patients with high-risk breast cancer.
Watch internationally renowned experts discuss the diagnosis and management of patients with ALK+ NSCLC, review the changing treatment landscape and consider how to optimize outcomes.
Watch the footage from our Satellite Symposium at ESMO-IO 2018, with internationally renowned expert faculty discussing the role of immunotherapy in the rapidly evolving treatment paradigm for NSCLC without an oncogenic driver mutation.
Watch a panel of internationally renowned experts discuss the factors influencing the choice of first-line treatment for patients with advanced soft tissue sarcoma and the interpretation of data from clinical trials in this patient population.
Watch internationally renowned expert, Professor Stephen Johnston, discuss key data in advanced breast cancer presented at the San Antonio Breast Cancer Symposium (SABCS) 2018 Congress, 3–8 December 2018.
Watch leading breast cancer clinicians from Europe and Japan discuss the latest data from the San Antonio Breast Cancer Symposium (SABCS) 2018 Congress, 3-8 December 2018, and what they may mean for global and regional clinical practice.
Watch internationally renowned expert, Dr Javier Cortés, discuss key data in advanced breast cancer presented at the European Society for Medical Oncology (ESMO) 2018 Congress, Munich, Germany.
Watch leading breast cancer clinicians from Europe and Japan discuss the latest data from the European Society for Medical Oncology (ESMO) 2018 Congress, Munich, Germany, and what they may mean for global and regional clinical practice.
Watch a group of leading breast cancer specialists debate and discuss how to optimize clinical outcomes for patients with advanced HR+/HER2- disease in the era of CDK4/6 inhibition.
Watch internationally renowned breast cancer expert, Professor Nadia Harbeck, discuss key data in advanced breast cancer presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, USA.
Watch internationally renowned breast cancer clinicians discussing the latest data from the American Society of Clinical Oncology (ASCO) Annual Meeting 2018, Chicago, IL, US, June 1–5, and what they may mean for clinical practice.
Watch internationally renowned breast cancer clinicians discussing the latest data from the American Association for Cancer Research (AACR) Annual Meeting 2018, Chicago, IL, US, April 14–18, and what they may mean for clinical practice.
Watch internationally renowned clinical expert, Professor Angelo Di Leo, discuss key data in advanced breast cancer presented at the 2018 American Association for Cancer Research (AACR) Annual Meeting, Chicago, USA.
